{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:53:40Z","timestamp":1792587220567,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.arth.2021.06.001","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T12:41:10Z","timestamp":1623328870000},"page":"3589-3592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["No Increased Risk of Venous Thromboembolism in High-Risk Patients Continuing Their Dose of 75 mg Aspirin Compared to Healthier Patients Given Low-Molecular-Weight Heparin"],"prefix":"10.1016","volume":"36","author":[{"given":"Oystein","family":"Hovik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar J.","family":"Amlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7408-3908","authenticated-orcid":false,"given":"Kjersti Kaul","family":"Jenssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2 Suppl","key":"10.1016\/j.arth.2021.06.001_bib1","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.arth.2021.06.001_bib2","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.arth.2016.04.004","article-title":"Aspirin as thromboprophylaxis in hip and knee arthroplasty: a systematic review and meta-analysis","volume":"31","author":"An","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.06.001_bib3","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s11999-017-5394-6","article-title":"Venous thromboembolism prophylaxis after TKA: aspirin, warfarin, enoxaparin, or factor Xa inhibitors?","volume":"475","author":"Bala","year":"2017","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2021.06.001_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.arth.2009.07.021","article-title":"Venous thromboembolism: management by American Association of Hip and Knee Surgeons","volume":"25","author":"Markel","year":"2010","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.06.001_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13018-016-0456-0","article-title":"Impact of recent guideline changes on aspirin prescribing after knee arthroplasty","volume":"11","author":"Shah","year":"2016","journal-title":"J\u00a0Orthop Surg Res"},{"key":"10.1016\/j.arth.2021.06.001_bib6","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.arth.2019.02.006","article-title":"Current practice trends in primary hip and knee arthroplasties among members of the American Association of Hip and Knee Surgeons: a long-term update","volume":"34","author":"Abdel","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.06.001_bib7","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2106\/JBJS.L.00400","article-title":"Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty","volume":"95","author":"Schousboe","year":"2013","journal-title":"The J bone Jt Surg Am volume"},{"key":"10.1016\/j.arth.2021.06.001_bib8","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.3760\/cma.j.issn.0366-6999.20132175","article-title":"Aspirin combined with mechanical measures to prevent venous thromboembolism after total knee arthroplasty: a randomized controlled trial","volume":"127","author":"Jiang","year":"2014","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.arth.2021.06.001_bib9","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1016\/j.arth.2017.01.009","article-title":"A\u00a0comparison of two dosing regimens of ASA following total hip and knee arthroplasties","volume":"32","author":"Feldstein","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.06.001_bib10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1712746","article-title":"Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty","volume":"378","author":"Anderson","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.arth.2021.06.001_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.arth.2005.04.031","article-title":"Deep vein thrombosis prevention in joint arthroplasties: continuous enhanced circulation therapy vs low molecular weight heparin","volume":"21","author":"Gelfer","year":"2006","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.06.001_bib12","series-title":"Venous thromboembolism in over 16s: Reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism","author":"National Guideline Centre (UK)","year":"2018"},{"key":"10.1016\/j.arth.2021.06.001_bib13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/jamainternmed.2019.6108","article-title":"Clinical effectiveness and safety of aspirin for venous thromboembolism prophylaxis after total hip and knee replacement: a systematic review and meta-analysis of randomized clinical trials","volume":"180","author":"Matharu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.arth.2021.06.001_bib14","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/j.arth.2020.04.088","article-title":"Is aspirin as effective as the newer direct oral anticoagulants for venous thromboembolism prophylaxis after total hip and knee arthroplasty? An analysis from the National Joint Registry for England, Wales, Northern Ireland, and the Isle of Man","volume":"35","author":"Matharu","year":"2020","journal-title":"J\u00a0Arthroplasty"},{"issue":"6 Suppl 2","key":"10.1016\/j.arth.2021.06.001_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.arth.2006.05.017","article-title":"VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty","volume":"21","author":"Westrich","year":"2006","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.06.001_bib16","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1302\/0301-620X.94B7.29129","article-title":"The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after knee replacement: a non-randomised comparison using National Joint Registry Data","volume":"94","author":"Jameson","year":"2012","journal-title":"J\u00a0Bone Joint Surg Br"},{"key":"10.1016\/j.arth.2021.06.001_bib17","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1007\/s11999-010-1411-8","article-title":"What are the risk factors for infection in hemiarthroplasties and total hip arthroplasties?","volume":"468","author":"Cordero-Ampuero","year":"2010","journal-title":"Clin Orthop Relat Res"},{"issue":"9 Suppl","key":"10.1016\/j.arth.2021.06.001_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.arth.2015.07.001","article-title":"Administration of aspirin as a prophylaxis agent against venous thromboembolism results in lower incidence of periprosthetic joint infection","volume":"30","author":"Huang","year":"2015","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.06.001_bib19","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/j.arth.2018.03.001","article-title":"Low-dose aspirin is safe and effective for venous thromboembolism prophylaxis following total knee arthroplasty","volume":"33","author":"Faour","year":"2018","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.06.001_bib20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1302\/0301-620X.98B3.36511","article-title":"Aspirin for thromboprophylaxis after primary lower limb arthroplasty: early thromboembolic events and 90 day mortality in 11,459 patients","volume":"98-B","author":"Ogonda","year":"2016","journal-title":"Bone Joint J"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540321005416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540321005416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:38:19Z","timestamp":1760121499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540321005416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0883540321005416"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2021.06.001","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No Increased Risk of Venous Thromboembolism in High-Risk Patients Continuing Their Dose of 75 mg Aspirin Compared to Healthier Patients Given Low-Molecular-Weight Heparin","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2021.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}